These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2820404)

  • 1. Rat transformation-associated proteins (TAP) induced by Moloney murine sarcoma virus interact with specific receptors on normal rat kidney cells.
    Li WJ; Steck P; Bowen JM; Chan JC
    Biochem Biophys Res Commun; 1987 Aug; 147(1):513-8. PubMed ID: 2820404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody study of the subcellular localization and DNA-stimulating activity of murine sarcoma virus-activated transformation-associated proteins.
    Li W; Chi K; Gallick GE; Chan JC
    Virology; 1987 Jan; 156(1):91-100. PubMed ID: 3027972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody detection of transformation associated protein (TAP) in ts110 Moloney murine sarcoma virus transformed 6M2 cells that are different from the mos gene product.
    Chan JC; Keck ME; Li W
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1223-30. PubMed ID: 3004486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperature-sensitive synthesis of a metalloproteinase in ts110-MSV-M-transformed NRK cells.
    Chan JC; Scanlon M; Zhang HZ; Murray JL
    Biochem Biophys Res Commun; 1991 Jul; 178(2):453-9. PubMed ID: 1859404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion, glycosylation, and phosphorylation of rat-specific, transformation-associated proteins in Moloney murine sarcoma virus-transformed rat cells.
    Li WJ; Chan JC
    Cancer Res; 1989 Apr; 49(7):1746-51. PubMed ID: 2538234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate preference of metalloproteinases secreted by ts-110 Moloney murine sarcoma virus-transformed normal rat kidney cells.
    Zhang HZ; Scanlon M; Murray JL; Chan JC
    Biochem Biophys Res Commun; 1992 Nov; 189(1):21-6. PubMed ID: 1449476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of transforming growth factors by simian sarcoma virus-transformed cells.
    van Zoelen EJ; van Rooijen MA; van Oostwaard TM; de Laat SW
    Cancer Res; 1987 Mar; 47(6):1582-7. PubMed ID: 3028611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factors released from Kirsten sarcoma virus transformed cells do not compete for epidermal growth factor membrane receptors.
    Chua CC; Geiman D; Ladda RL
    J Cell Physiol; 1983 Oct; 117(1):116-22. PubMed ID: 6311845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overproduction of metalloproteinases by v-mos-transformed rat kidney (6m2) cells.
    Chan JC
    Leukemia; 1992; 6 Suppl 3():168S-170S. PubMed ID: 1602817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of specific transformation-associated proteins (TAPs) in two rat cell lines is closely related to the expression of the v-mos gene product of Moloney murine sarcoma virus (Mo-MSV).
    Li W; Bowen JM; Chan JC
    Intervirology; 1987; 28(1):50-6. PubMed ID: 2828268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factors: sources, properties and possible roles in normal and malignant cell growth control.
    Brown KD; Blakeley DM
    Biochem Soc Trans; 1984 Apr; 12(2):168-73. PubMed ID: 6327426
    [No Abstract]   [Full Text] [Related]  

  • 12. Phenotypic transformation of normal rat kidney cells in a growth-factor-defined medium: induction by a neuroblastoma-derived transforming growth factor independently of the EGF receptor.
    van Zoelen EJ; van Oostwaard TM; van der Saag PT; de Laat SW
    J Cell Physiol; 1985 May; 123(2):151-60. PubMed ID: 2984216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonfunctional epidermal growth factor receptor in cells transformed by Kirsten sarcoma virus.
    Chua CC; Geiman DE; Schreiber AB; Ladda RL
    Biochem Biophys Res Commun; 1984 Jan; 118(2):538-47. PubMed ID: 6322750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of epidermal growth factor receptors and release of transforming growth factors do not correlate with sarcoma virus-transformation in clonally-related NIH/3T3-derived cell lines.
    Brown KD; Blakeley DM; Roberts P; Avery RJ
    Biochem J; 1985 Jul; 229(1):119-25. PubMed ID: 2994627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factors. Isolation, characterization, and interaction with cellular receptors.
    Massagué J
    Prog Med Virol; 1985; 32():142-58. PubMed ID: 2991987
    [No Abstract]   [Full Text] [Related]  

  • 17. Latent beta-transforming growth factor in nontransformed and Kirsten sarcoma virus-transformed normal rat kidney cells, clone 49F.
    Pircher R; Lawrence DA; Jullien P
    Cancer Res; 1984 Dec; 44(12 Pt 1):5538-43. PubMed ID: 6093998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine growth factors and cancer.
    Sporn MB; Roberts AB
    Nature; 1985 Feb 28-Mar 6; 313(6005):745-7. PubMed ID: 3883191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta modulates the high-affinity receptors for epidermal growth factor and transforming growth factor-alpha.
    Massagué J
    J Cell Biol; 1985 May; 100(5):1508-14. PubMed ID: 2985623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcoma growth factor and other transforming peptides produced by human cells: interactions with membrane receptors.
    Todaro GJ; De Larco JE; Fryling CM
    Fed Proc; 1982 Nov; 41(13):2996-3003. PubMed ID: 6292003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.